Scott Shandler, Ph.D., MBA, is the co-founder of Longevity Biotech. Prior to founding Longevity, Scott was a venture capitalist at BioAdvance, an early stage fund, where he was responsible for therapeutics, diagnostic and biomarker opportunities. At PolyMedix, Scott assisted with their successful Series A fundraising activities. His work history includes Accenture’s (ACN) Pharmaceutical and Medical Products group, Merck Research Labs (MRK), and Inventa.

Scott received his Ph.D. in Biochemistry and Molecular Biophysics from the University of Pennsylvania, an MBA in Health Care Management from The Wharton School, a Certificate of Bioinformatics from Stanford University, along with a B.A. in Computer Science from Brandeis University. He has published in leading peer-reviewed journals, is an inventor on multiple patents and has served as Principal Investigator on federal and private grants.